Atlas Capital Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $593K | Sell |
|
|||||
|
2025
Q1 | $554K | Sell |
|
|||||
|
2024
Q4 | $905K | Sell |
|
|||||
|
2024
Q3 | $777K | Sell |
|
|||||
|
2024
Q2 | $713K | Buy |
|
|||||
|
2024
Q1 | $617K | Buy |
|
|||||
|
2023
Q4 | $12.9K | Hold |
|
|||||
|
2023
Q3 | $12.6K | Hold |
|
|||||
|
2023
Q2 | $9.34K | Sell |
|
|||||
|
2023
Q1 | $194K | Hold |
|
|||||
|
2022
Q4 | $200K | Hold |
|
|||||
|
2022
Q3 | $177K | Buy |
|
|||||
|
2022
Q2 | $95.3K | Hold |
|
|||||
|
2022
Q1 | $119K | Buy |
|
|||||
|
2021
Q4 | $85.6K | Buy |
|
|||||
|
2021
Q3 | $78.1K | Hold |
|
|||||
|
2021
Q2 | $79.4K | Hold |
|
|||||
|
2021
Q1 | $92.6K | Sell |
|
|||||
|
2020
Q4 | $120K | Hold |
|
|||||
|
2020
Q3 | $112K | Hold |
|
|||||
|
2020
Q2 | $154K | Sell |
|
|||||
|
2020
Q1 | $118K | Buy |
|
|||||
|
2019
Q4 | $705 | Hold |
|
|||||
|
2019
Q3 | $495 | Sell |
|
|||||
|
2019
Q2 | $65.5K | Sell |
|
|||||
|
2019
Q1 | $512K | Sell |
|
|||||
|
2018
Q4 | $512K | Buy |
|
|||||
|
2018
Q3 | $563K | Sell |
|
|||||
|
2018
Q2 | $823K | Sell |
|
|||||
|
2018
Q1 | $655K | Buy |
|